BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21117999)

  • 21. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
    Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
    J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A quantitative method to measure telomerase activity by bioluminescence connected with telomeric repeat amplification protocol.
    Xu S; He M; Yu H; Cai X; Tan X; Lu B; Shu B
    Anal Biochem; 2001 Dec; 299(2):188-93. PubMed ID: 11730342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Telomere lengths and telomerase activity in liposarcomas].
    Schneider-Stock R; Eppler C; Walter H; Radig K; Haeckel C; Hoang-Vu C; Epplen JT; Roessner A
    Verh Dtsch Ges Pathol; 1998; 82():226-31. PubMed ID: 10095439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of telomerase activity and telomere length.
    Wu KD; Moore MA
    Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-color real-time telomeric repeat amplification protocol.
    Fajkus J; Koppová K; Kunická Z
    Biotechniques; 2003 Nov; 35(5):912-4. PubMed ID: 14628661
    [No Abstract]   [Full Text] [Related]  

  • 26. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput analysis of telomerase by capillary electrophoresis.
    Atha DH; Miller K; Sanow AD; Xu J; Hess JL; Wu OC; Wang W; Srivastava S; Highsmith WE
    Electrophoresis; 2003 Jan; 24(1-2):109-14. PubMed ID: 12652580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonradioactive detection of telomerase activity using a PCR-ELISA-based telomeric repeat amplification protocol.
    Emrich T; Karl G
    Methods Mol Biol; 2002; 191():147-58. PubMed ID: 11951603
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay.
    Ohyashiki K; Ohyashiki JH; Nishimaki J; Toyama K; Ebihara Y; Kato H; Wright WE; Shay JW
    Cancer Res; 1997 Jun; 57(11):2100-3. PubMed ID: 9187102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
    Botchkina GI; Kim RH; Botchkina IL; Kirshenbaum A; Frischer Z; Adler HL
    Clin Cancer Res; 2005 May; 11(9):3243-9. PubMed ID: 15867219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells].
    Xiao CY; Zhou FX; Liu SQ; Xie CH; Dai J; Zhou YF
    Ai Zheng; 2005 Jun; 24(6):653-6. PubMed ID: 15946472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonradioactive telomerase activity assay by microchip electrophoresis: privileges to the classical gel electrophoresis assay.
    Zhelev Z; Bakalova R; Ewis A; Ohba H; Ishikawa M; Baba Y
    Electrophoresis; 2005 Aug; 26(15):3021-4. PubMed ID: 16078194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
    Wada Y; Yagihashi A; Kameshima H; Matsuura A; Sato N; Kikuchi K; Yajima T; Sasaki K; Uehara N; Watanabe N; Hirata K
    Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):451-7. PubMed ID: 9436045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
    Heine B; Hummel M; Müller M; Heicappell R; Miller K; Stein H
    J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of telomerase activity in Plasmodium falciparum using a nonradioactive method.
    Rubiano CC; Wasserman M
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):693-5. PubMed ID: 12973539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of telomeres and telomerase.
    Herbert BS; Shay JW; Wright WE
    Curr Protoc Cell Biol; 2003 Nov; Chapter 18():Unit 18.6. PubMed ID: 18228424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of telomerase activity in dog tumors.
    Yazawa M; Okuda M; Setoguchi A; Nishimura R; Sasaki N; Hasegawa A; Watari T; Tsujimoto H
    J Vet Med Sci; 1999 Oct; 61(10):1125-9. PubMed ID: 10563290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Techniques for detection of telomerase activity in tissue samples. Diagnostic and prognosis importance].
    Brousset P; al Saati T; Chaouche N; Zenou RC; Mazerolles C; Delsol G
    Ann Pathol; 1997 Oct; 17(5):364-8. PubMed ID: 9471158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of telomerase activity and its clinical application].
    Ohyashiki K; Ohyashiki JH; Yahata N; Toyama K
    Rinsho Byori; 1997 Dec; 45(12):1133-41. PubMed ID: 9437893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.